Companies in #ADHD
Found 1 company operating in this sector.
Public biopharma (Nasdaq: SUPN) developing and commercializing CNS therapeutics across epilepsy, migraine, Parkinson's disease, ADHD and postpartum depression; agreed to an all-stock merger with Indivior in 2026.